pembrolizumab
merck
['pembro', 'key,note,789', 'sclc', 'sting data,(-interesting data)', 'lcsm,(-blcsm)', 'nsclc']
keynote-789 #asco23 evaluating chemo+pembrolizumab vs chemo in egfrmut nsclc post-tki addition of pembrolizumab did not statistically significantly improve os or pfs important results that confirm existing data of limited activity of io in this population #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.